Vy Tran, PA
Medical · Oklahoma City, OKNPI 1801108311
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,229 of the $14,516 with a category attached, or 84.2%. It is spread thinly across 25 manufacturers, the largest accounting for just 12.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $5,120, 5.0 times the $1,031 reported in 2021. Among medical clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 519 payments — averaging $27.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$2K
- Lilly USA, LLC$2K
- E.r. Squibb & Sons, L.L.C.$2K
- Arcutis Biotherapeutics, Inc.$1K
- Novartis$1K
- Dermavant Sciences, Inc.$986
- plus $6K from 19 others
What the payments were for
- Consulting fees$1,89813%
- Travel & lodging$40%
- Food & beverage$12,22984%
- Education$3843%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 10 | $1,802 |
| Lilly USA, LLC | 56 | $1,672 |
| E.r. Squibb & Sons, L.L.C. | 19 | $1,501 |
| Arcutis Biotherapeutics, Inc. | 58 | $1,193 |
| Novartis | 87 | $1,103 |
| Dermavant Sciences, Inc. | 36 | $986 |
| Sanofi | 34 | $981 |
| AbbVie | 33 | $793 |
| Galderma Laboratories, L.p. | 34 | $668 |
| LEO Pharma Inc. | 38 | $653 |
| Pfizer | 23 | $628 |
| Regeneron Healthcare Solutions, Inc. | 22 | $517 |
| Incyte Corporation | 17 | $515 |
| UCB, Inc. | 9 | $465 |
| Johnson & Johnson | 7 | $240 |
| Journey Medical Corporation | 3 | $176 |
| Kyowa Kirin, Inc. | 3 | $164 |
| Sun Pharmaceutical Industries Inc. | 7 | $131 |
| Organon | 8 | $83 |
| Mayne Pharma Commercial LLC | 6 | $76 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $58 |
| Amgen | 3 | $55 |
| Genentech USA, Inc. | 1 | $21 |
| Botanix SB Inc | 1 | $18 |
| Kerecis Limited | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,516 in reported general payments places this provider in the 95th percentile of 370 medical providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 41 | $985 |
| Ketoconazole | 25 | $486 |
| Triamcinolone Acetonide | 44 | $410 |
| Hydrocortisone | 19 | $227 |
| Fluconazole | 20 | $217 |
| Minoxidil | 11 | $124 |
Paid to pharmacies, not to this prescriber.
Other medical in Oklahoma City
- Mebin ThomasOklahoma City$323K
- Kristine MurrowOklahoma City$81K
- Katelyn PuryearOklahoma City$22K
- Kelly WalworthOklahoma City$15K
- Jere ClaunchOklahoma City$15K
- Jennifer MinshallOklahoma City$11K
- Lindee LedbetterOklahoma City$10K
- Christina HelmsOklahoma City$7K
- John ParmeleeOklahoma City$6K
- Holly MaxOklahoma City$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.